Biosergen publishes interim report for fourth quarter 2022
Friday, March 31, 2023: Biosergen AB (“Biosergen” or the “Company”) thereby publishes the interim report for the fourth quarter 2022. The interim report is available as an attached document and on the company website (www.biosergen.net)Summary of the Interim Report for Q4 2022 2022 2021 2022 2021TSEK Oct-Dec Oct-Dec Jan-Dec Jan-Dec Other income 1.964 3.290 5.183 8.573Profit/loss before depreciation (EBITDA) -12.491 -9.876 -39.987 -34.